There is increasing evidence that high blood and tissue glucose levels may be an important risk factor for many non communicable diseases.

CGM monitoring should be considered in all patients affected by heart disease, in order to define glucotype and current glucose profile- both easily treated if 'unhealthy' .

Read more about glucose here

https://www.scvc.co.uk/news/why-glucose-may-be-the-most-important-modifiable-risk-factor-for-humans/